$40.500
+0.324 (+0.80%)收盘时
CNTA 资讯
CNTA 事件
Centessa to be Acquired by Eli Lilly for $38 per Share
Centessa (CNTA) which entered into a definitive agreement relating to its proposed acquisition by Eli Lilly (LLY), through a wholly owned subsidiary, announced that the High Court of Justice of England and Wales has approved the proposal for Lilly to acquire Centessa for $38.00 in cash per share plus one non-transferable contingent value right that entitles the holder to receive up to an aggregate of $9.00 subject to the achievement of three milestones, for a total transaction value of approximately $7.8B. The transaction is being implemented by way of a court-sanctioned scheme of arrangement under English law. Centessa announced that the court has issued the court order sanctioning the scheme. Closing of the transaction will occur and the Scheme will become effective upon the court order being delivered to the Registrar of companies, which is expected to occur on June 24. The last day of trading of Centessa American depositary shares on Nasdaq is expected to be tomorrow, June 23, with trading in Centessa ADSs on Nasdaq being halted before the opening of trading on June 24.
LifeSci Capital Downgrades Centessa to Market Perform After Eli Lilly Acquisition
LifeSci Capital downgraded Centessa (CNTA) to Market Perform from Outperform after Eli Lilly (LLY) announced an agreement to acquire the company for $38 per share in cash plus a non-transferable contingent value right worth up to $9 per share.
Dow Jones Index Rises 2.49% to 46,341.51
The major averages closed sharply higher in a positive end to an otherwise difficult March that saw the S&P 500 and Nasdaq suffer their weakest monthly performances in several years amid continued conflict in the Middle East. The Wall Street Journal is reporting that President Trump has told aides he may be willing to end military activities even if the Strait of Hormuz stayed mostly closed, while reports quote the Islamic Republic News Agency as having indicated that Iran's President is ready to work toward ending the war, but seeks guarantees.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiaisin Marvellas part of a strategic partnership over silicon photonics technologyBiogenApellisfor $41 per share in cash at closing, or $5.6BEli LillyCentessafor $38 per share in cash plus one contingent value rightMcCormickagreed to combine with Unilever'sFoods businessKKRand Taiyo reached a2. WALL STREET CALLS:Ferrarito Buy from Hold at JefferiesBernsteinWestern Digitalon attractive entry post selloffPhreesiato Neutral or equivalent ratings at Baird, Truist, Citi and JPMorganTDColgate-Palmoliveon higher oil-based input costsWall Street rolled outof MiniMedwith mostly Buy or equivalent ratings3. AROUND THE WEB:Ciscohas suffered a cyberattack after threat actors used stolen credentials from the recent Trivy supply chain attack to breach its internal development environment and steal source code belonging to the company and its customers, BleepingComputer saysSwiss senior parliamentarians have told UBSexecutives they would create a compromise related to the new rules as Bern finalizes a decision on how much capital the bank should hold, FT saysIrenic Capital Management has built a position in Snapand is pushing for changes at the social media company to improve financial and operating performance, Bloomberg saysNetflixis considering expanding its current two-game package to four games, WSJ reportsAppeals court denies reviving criminal case against Boeing, Bloomberg says4. MOVERS:Agios Pharmaceuticalsincreases after announcing it will pursue U.S. acceleratedWeRidegains after launching fully driverlessin Dubai with UberAehr Testhigher after receiving afor wafer-level test and burn-in of silicon photonics integrated circuitsT1 Energylower afterand maintaining its guidance for FY26Constellation Energyfalls after 2026 guidance5. EARNINGS/GUIDANCE:Hersheyprovided adjusted EPS and revenue growthPurple Innovationand provided guidance for Q1 and FY26FactSetand raised its guidance for FY26J.Jill, with EPS and revenue beating consensusTD Synnex, with CEO Patrick Zammit commenting, "We're pleased with how we've started fiscal 2026"INDEXES:The Dow rose 1,125.37, or 2.49%, to 46,341.51, the Nasdaq gained 795.99, or 3.83%, to 21,590.63, and the S&P 500 advanced 184.80, or 2.91%, to 6,528.52.
Alkermes Shares Rise 15% Following M&A Activity
Alkermes (ALKS) rose 15% after Eli Lilly (LLY) agreed to acquire Centessa Pharmaceuticals (CNTA), reflecting renewed M&A momentum in biotech, Leerink tells investors in a research note. While the boost highlights Alkermes' strong orexin franchise, the stock could also attract interest from other large pharma companies seeking a presence in this therapeutic area, the firm says. Leerink has a Market Perform rating on Alkermes shares.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。